Skip to main content
Krsnaa Diagnostics Limited logo

Krsnaa Diagnostics Limited — Investor Relations & Filings

Ticker · KRSNAA ISIN · INE08LI01020 LEI · 335800BHDTJRKNTQ1O55 BSE.NS Human health and social work activities
Open in API
Filings indexed 617 across all filing types
Latest filing 2026-05-25 Audit Report / Informat…
Country IN India
Listing BSE.NS KRSNAA

About Krsnaa Diagnostics Limited

https://krsnaadiagnostics.com/

Krsnaa Diagnostics Limited is a specialized provider of diagnostic services, focusing on radiology and pathology. The company operates an extensive network of centers, primarily utilizing a Public-Private Partnership (PPP) model to deliver medical imaging and laboratory services. Its radiology portfolio includes Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, X-rays, and Mammography, while its pathology division offers a wide array of clinical laboratory tests. A core technical feature is its integrated tele-radiology platform, which facilitates remote image interpretation by specialists to ensure rapid reporting. The company emphasizes high-quality, affordable diagnostics, targeting both public health systems and private patients. Its operational model is built on large-scale infrastructure and advanced technological integration to provide accessible diagnostic solutions across diverse geographic regions.

Recent filings

Filing Released Lang Actions
Dividend
Audit Report / Information Classification · 90% confidence The document is a formal Board Meeting outcome under SEBI Listing Regulations that includes the approved Audited Standalone and Consolidated Financial Results for the year ended March 31, 2026, accompanied by the Independent Auditor’s Report and detailed financial statements. This is not merely an earnings announcement (ER) or a short notice of report publication (RPA), but the actual audited financial results with the statutory audit opinion, fitting the definition of a standalone Audit Report / Information filing (AR).
2026-05-25 English
Recommendation of Final Dividend
Audit Report / Information Classification · 91% confidence The document is the formal outcome of the Board meeting approving the audited standalone and consolidated financial results for the year ended March 31, 2026, and includes the full Independent Auditor’s Report on those results. It is not merely a brief earnings release or notice of publication, nor is it a complete annual report with MD&A; rather it is a standalone audit report and the associated audited financial statements submitted under SEBI Listing Regulations. Therefore, it best fits the Audit Report / Information category.
2026-05-25 English
Financial Results for Quarter and Year ended on March 31, 2026
Regulatory Filings Classification · 85% confidence The document is a compliance filing under the SEBI Listing Regulations (Regulation 33) announcing the outcome of a Board meeting, including approval of audited standalone and consolidated financial results for the year ended March 31, 2026, the auditors’ report, and the full set of audited financial statements. It is not a full Annual Report (10-K) or an interim/quarterly report but rather a regulatory announcement of results and related governance matters submitted to the stock exchanges. This best fits the catch-all Regulatory Filings category (RNS).
2026-05-25 English
Outcome of Board Meeting
Earnings Release Classification · 80% confidence The document is headed “Outcome of Board Meeting held on May 25, 2026” and is submitted to the BSE and NSE under SEBI Listing Regulations, disclosing the Board’s approval of the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with the independent auditor’s report. It is not a full Annual Report (10-K) but rather the initial public release of periodical financial results. Hence it falls under the Earnings Release category. FY 2026
2026-05-25 English
Outcome of Board Meeting held on May 25, 2026
Interim / Quarterly Report Classification · 85% confidence The document is a mandatory disclosure to stock exchanges under SEBI Listing Regulations (Reg. 30 and 33) announcing and enclosing the board’s approval of the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, together with the independent auditor’s report and full financial tables. This is not a full narrative Annual Report (10-K), nor merely an earnings highlight (ER), but rather the detailed periodic financial results required by regulation. It therefore best fits the Interim/Quarterly Report category (IR). FY 2026
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 15% confidence The document is a notice under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges and investors of an upcoming post-earnings conference call. It contains no financial statements, earnings data or actual transcript; it is purely an invitation/disclosure. This does not qualify as an earnings release or transcript, nor a formal quarterly/interim report. Therefore it falls into the general “Regulatory Filings” category for miscellaneous exchange disclosures.
2026-05-21 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.